Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-06-06 | 2017-08-16 | 12064 |
| APO-GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-08-21 | 2017-10-04 | 20000 |
| APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-03-11 | 2017-03-29 | 604 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-03-11 | 2017-07-13 | 661 |
| APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-04-07 | 2017-09-15 | 5897 |
| APO-GABAPENTIN | 100MG | CAPSULE | Resolved | 2020-01-15 | 2020-02-10 | 103365 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2018-04-02 | 2018-08-21 | 44497 |
| APO-GAIN LIQ 20MG/ML | 20MG | LIQUID | Resolved | 2017-04-12 | 2018-02-26 | 6554 |
| APO-GATIFLOXACIN | 0.3% | SOLUTION | Resolved | 2024-03-27 | 2024-04-12 | 223555 |
| APO-GATIFLOXACIN | 0.3% | SOLUTION | Resolved | 2023-09-28 | 2023-11-24 | 205486 |
| APO-GEFITINIB | 250MG | TABLET | Resolved | 2022-04-14 | 2022-06-24 | 158819 |
| APO-GEMFIBROZIL | 600MG | TABLET | Resolved | 2017-03-11 | 2019-11-26 | 610 |
| APO-GEMFIBROZIL CAP 300MG USP | 300 MG | CAPSULE | Resolved | 2017-03-11 | 2019-06-12 | 607 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2017-10-17 | 2018-05-22 | 26159 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-06-20 | 2024-08-02 | 231033 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-09-27 | 2024-11-22 | 238838 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-01-26 | 2024-03-15 | 217487 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-03-01 | 2024-03-15 | 221093 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-04-05 | 2024-06-07 | 224583 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-04-19 | 2024-06-07 | 225799 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |